share_log

Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink

Dow Jones Newswires ·  Mar 19, 2021 18:30

DJ Innate Pharma Is Maintained at Market Perform by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings

(END) Dow Jones Newswires

March 19, 2021 06:30 ET (10:30 GMT)

DJ Innate Pharma Price Target Raised to $7.00/Share From $5.00 by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/IPHA/ratings

(END) Dow Jones Newswires

March 19, 2021 06:30 ET (10:30 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment